Close the acquisition of Bardy Diagnostics, Inc
Not delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 19 Jan 2021
- Due
- 31 Mar 2021
- Checked
- 24 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“expects to close the transaction in the fiscal second quarter of 2021, subject to customary closing conditions.”
What we found
Evidence strength A What the grades mean
Hill-Rom did not close the acquisition by the fiscal second quarter of 2021, citing a material adverse effect due to reimbursement rate reductions, leading to litigation with Bardy Diagnostics.
-
A Hill-Rom Holdings, Inc. 10-Q filed 2021-04-30
“For the six months ended March 31, 2021, we did not close on any new business acquisitions.” ✓ confirmed on the page
-
A Hill-Rom Holdings, Inc. 10-Q filed 2021-04-30
“As a result of the unexpected Novitas reimbursement rate reduction, Hillrom asserted that a "Company Material Adverse Effect" has occurred, and therefore the closing conditions have not been satisfied.” ✓ confirmed on the page
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- acquisition of Bardy Diagnostics, Inc.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to customary closing conditions
- Depends on
- Regulatory, Counterparty
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
- Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Hill-Rom Holdings, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C047518-022167 · Corrections policy